Genomic change in hepatitis B virus associated with development of hepatocellular carcinoma

doi:10.3748/wjg.v22.i23.5393

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 22, Issue 23

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (7426)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-4) series, Tables (1-3) series.

Item

Count

PDF

678

WORD

178

HTML

3545

Figures (1-4)

167

Tables (1-3)

137

Sum=4705

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1026

Download

1695

Sum=2721

Jun 21, 2016 (publication date) through May 9, 2024

Times Cited of This Article

Times Cited (9)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Cohort Study

World J Gastroenterol. Jun 21, 2016; 22(23): 5393-5399
Published online Jun 21, 2016. doi: 10.3748/wjg.v22.i23.5393

Table 2 Univariate analysis of risk factors for hepatocellular carcinoma development

Variables	RR (95%CI)	P value
Genomic changes
C1653T in X region	1.583 (0.176-14.210)	NS
T1753V in X region	17.565 (1.956-157.737)	< 0.01
A1762T/G1764A in BCP	30.512 (0.004-230706)	NS
G1896A in PC	5.765 (0.519-64.076)	NS
Pre-S deletion	2.491 (0.502-12.370)	NS
Clinical characteristics
Age > 50 yr	57.5 (0.035-93428)	NS
Male	27.3 (0.001-547718)	NS
ALT > 80 IU/L	0.55 (0.091-3.29)	NS
PT ≤ 70 %	4.12 (0.682-24.845)	NS
Serum AFP > 200 ng/mL	0.044 (0.00-209046)	NS
HBeAg positive	0.034 (0.00-360.724)	NS
HBV DNA > 10⁵ copies/mL	0.741 (0.123-4.452)	NS

RR: Relative risk; CI: Confidence interval; NS: Not significant; BCP: Basal core promoter; PC: Precore; ALT: Alanine aminotransferase; PT: Prothrombin time; AFP: α-fetoprotein; HBeAg: Hepatitis B e antigen.

Citation: Lee D, Lyu H, Chung YH, Kim JA, Mathews P, Jaffee E, Zheng L, Yu E, Lee YJ, Ryu SH. Genomic change in hepatitis B virus associated with development of hepatocellular carcinoma. World J Gastroenterol 2016; 22(23): 5393-5399
URL: https://www.wjgnet.com/1007-9327/full/v22/i23/5393.htm
DOI: https://dx.doi.org/10.3748/wjg.v22.i23.5393